A Phase 2, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis.
Phase of Trial: Phase II
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Plantar fasciitis
- Focus Therapeutic Use
- Sponsors Revance Therapeutics
- 09 Aug 2017 Status changed from active, no longer recruiting to suspended.
- 27 Apr 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.
- 27 Apr 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.